264 related articles for article (PubMed ID: 26089220)
1. ACR Appropriateness Criteria® Ductal Carcinoma in Situ.
Kaufman SA; Harris EE; Bailey L; Chadha M; Dutton SC; Freedman GM; Goyal S; Halyard MY; Horst KC; Novick KL; Park CC; Suh WW; Toppmeyer D; Zook J; Haffty BG
Oncology (Williston Park); 2015 Jun; 29(6):446-58, 460-1. PubMed ID: 26089220
[TBL] [Abstract][Full Text] [Related]
2. ACR appropriateness criteria(®) ductal carcinoma in situ.
Moran MS; Bai HX; Harris EE; Arthur DW; Bailey L; Bellon JR; Carey L; Goyal S; Halyard MY; Horst KC; MacDonald SM; Haffty BG;
Breast J; 2012; 18(1):8-15. PubMed ID: 22107336
[TBL] [Abstract][Full Text] [Related]
3. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
4. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
Sakorafas GH; Tsiotou AG
Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
[TBL] [Abstract][Full Text] [Related]
5. ACR Appropriateness Criteria® local-regional recurrence (LR) and salvage surgery: breast cancer.
Halyard MY; Wasif N; Harris EE; Arthur DW; Bailey L; Bellon JR; Carey L; Goyal S; Horst KC; Moran MS; MacDonald SM; Haffty BG;
Am J Clin Oncol; 2012 Apr; 35(2):178-82. PubMed ID: 22433995
[TBL] [Abstract][Full Text] [Related]
6. Quality indicators for ductal carcinoma in situ (DCIS) of the breast: development using a multidisciplinary delphi process and its use in monitoring population-based treatment.
Chin-Lenn L; Craighead P; Bryant HE; Mack L; Temple W; Ghali W; Quan ML
J Surg Oncol; 2013 Nov; 108(6):348-51. PubMed ID: 24038038
[TBL] [Abstract][Full Text] [Related]
7. ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer.
Jolly S; Soni P; Gaffney DK; Biagioli M; Elshaikh MA; Jhingran A; Kidd E; Lee LJ; Li L; Moore DH; Rao GG; Wahl AO; Williams NL; Yashar CM; Small W
Oncology (Williston Park); 2015 Nov; 29(11):867-72, 874-5. PubMed ID: 26568534
[TBL] [Abstract][Full Text] [Related]
8. ACR appropriateness criteria® locally advanced breast cancer.
Macdonald SM; Harris EE; Arthur DW; Bailey L; Bellon JR; Carey L; Goyal S; Halyard MY; Horst KC; Moran MS; Haffty BG
Breast J; 2011; 17(6):579-85. PubMed ID: 21906206
[TBL] [Abstract][Full Text] [Related]
9. The surgical management of ductal carcinoma in situ.
Kumar S; Sacchini V
Breast J; 2010; 16 Suppl 1():S49-52. PubMed ID: 21050311
[TBL] [Abstract][Full Text] [Related]
10. ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancer.
Halyard MY; Harris EE; Bailey L; Bellon JR; Freedman GM; Goyal S; Horst KC; Moran MS; Park CC; Suh WW; Toppmeyer D; Haffty BG
Oncology (Williston Park); 2014 Feb; 28(2):157-64, C3. PubMed ID: 24701707
[TBL] [Abstract][Full Text] [Related]
11. Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.
Coates AS; Winer EP; Goldhirsch A; Gelber RD; Gnant M; Piccart-Gebhart M; Thürlimann B; Senn HJ;
Ann Oncol; 2015 Aug; 26(8):1533-46. PubMed ID: 25939896
[TBL] [Abstract][Full Text] [Related]
12. Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.
Prescrire Int; 2013 Dec; 22(144):298-303. PubMed ID: 24600734
[TBL] [Abstract][Full Text] [Related]
13. Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.
Cutuli B; De Lafontan B; Kirova Y; Auvray H; Tallet A; Avigdor S; Brunaud C; Delva C
Radiat Oncol; 2015 May; 10():110. PubMed ID: 25944033
[TBL] [Abstract][Full Text] [Related]
14. Ductal carcinoma in situ: a disease entity that merits more recognition.
Dereere E; Papadimitriou K; Tjalma W; Altintas S
Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
[TBL] [Abstract][Full Text] [Related]
15. National Breast Cancer Audit: ductal carcinoma in situ management in Australia and New Zealand.
Cuncins-Hearn A; Boult M; Babidge W; Zorbas H; Villanueva E; Evans A; Oliver D; Kollias J; Reeve T; Maddern G
ANZ J Surg; 2007; 77(1-2):64-8. PubMed ID: 17295824
[TBL] [Abstract][Full Text] [Related]
16. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
17. Premalignant lesions: diagnosis, evaluation, and management.
Tejada-Berges T
Clin Obstet Gynecol; 2011 Mar; 54(1):133-40. PubMed ID: 21278512
[TBL] [Abstract][Full Text] [Related]
18. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
Mokbel K
Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
[TBL] [Abstract][Full Text] [Related]
19. Recent advances and current controversies in the management of DCIS of the breast.
Sakorafas GH; Farley DR; Peros G
Cancer Treat Rev; 2008 Oct; 34(6):483-97. PubMed ID: 18490111
[TBL] [Abstract][Full Text] [Related]
20. Ductal carcinoma in situ.
Bleicher RJ
Surg Clin North Am; 2013 Apr; 93(2):393-410. PubMed ID: 23464692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
